Are you a journalist? Please sign up here for our press releases
Subscribe to our monthly newsletter:
Multiple sclerosis
03.05.2023
Focusing on the ups and downs of multiple sclerosis, Weizmann Institute researchers discover a major player in its remission
21.10.2014
Combining two technologies makes a drug compound stronger and longer-lasting
16.01.2014
The molecule that helps HIV invade immune cells might, in the future, help prevent autoimmune attacks
19.05.2013
Yeda Research and Development Company, Ltd., was established in 1959 to...
10.10.2010
from the institute to Teva Pharmaceuticals Ltd.
12.09.2010
In the 1950s, Prof. Ephraim Katzir developed simple synthetic models, known as polyamino acids, that...
08.09.2010
Prof. Michel Revel spent more than 30 years studying interferons, which play a key role in the immune system. In the late 1970s, he isolated the...
10.10.2007
Israeli scientists identify: Genes that Affect Responses of Multiple Sclerosis Patients to Copaxone®
...
26.06.2007
Weizmann Institute Scientists reveal a mechanism for healthy nerve development, which may...
01.05.2001
Genetically engineered "draw-fire" proteins may lead to a new treatment for autoimmune diseases
